Pharmacokinetic effect of aprepitant on irinotecan in patients with colorectal cancer

被引:0
|
作者
Nieva, J. J.
Webb, W.
Siuzdak, G.
机构
[1] Scripps Canc Ctr, La Jolla, CA USA
[2] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
19622
引用
收藏
页数:1
相关论文
共 50 条
  • [11] EFFECT OF ENZASTAURIN IN PATIENTS WITH COLORECTAL CANCER TREATED WITH IRINOTECAN PLUS CETUXIMAB
    Iqbal, S.
    Miller, C.
    Figueroa, J.
    Hossain, A.
    Nicol, S.
    Mulcahy, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 66 - 66
  • [12] Oxaliplatin plus irinotecan and FU-FOL combination and pharmacokinetic analysis in advanced colorectal cancer patients
    Gil-Delgado, MA
    Bastian, G
    Guinet, FO
    Spano, JP
    Taillibert, S
    Rocher, MA
    Castaing, D
    Adam, R
    Urien, S
    Bismuth, H
    Khayat, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 294 - 298
  • [13] Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
    Oyaga-Iriarte, Esther
    Insausti, Asier
    Sayar, Onintza
    Aldaz, Azucena
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 140 (01) : 20 - 25
  • [14] Efficacy and toxicity of irinotecan in patients with colorectal cancer
    Rothenberg, ML
    SEMINARS IN ONCOLOGY, 1998, 25 (05) : 39 - 46
  • [15] Toxicity of irinotecan in patients with colorectal cancer.
    Van Cutsem, E
    Douillard, JY
    Köhne, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18): : 1351 - 1352
  • [16] Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients
    Gupta, E
    Mick, R
    Ramirez, J
    Wang, XL
    Lestingi, TM
    Vokes, EE
    Ratain, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1502 - 1510
  • [17] Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with Testicular Cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction
    Strik, Jeffrey
    de Jong, Loek A. W.
    Sijm, Joost
    Desar, Ingrid M. E.
    van Erp, Nielka P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (01) : 135 - 138
  • [18] Irinotecan in the treatment of elderly patients with advanced colorectal cancer
    Sastre, Javier
    Puente, Javier
    Garcia-Saenz, Jose A.
    Diaz-Rubio, Eduardo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (03) : 250 - 255
  • [19] Cetuximab plus irinotecan in refractory colorectal cancer patients
    Delgao, Marian Gil
    Spano, Jean-Philippe
    Khayat, David
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 407 - 413
  • [20] IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2008, 14 (01): : 48 - 50